Drugs.com - FDA MedWatch Alerts

Provepharm Inc. Issues Recall of One Lot of Phenylephrine Hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) Due to Presence of Particulate Matter

Audience: Pharmacy, Consumer January 24, 2025 – Collegeville, Pennsylvania, Provepharm Inc. is voluntarily recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk...

Feb 9, 2025 - 21:44
 0
Provepharm Inc. Issues Recall of One Lot of Phenylephrine Hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) Due to Presence of Particulate Matter
Audience: Pharmacy, Consumer January 24, 2025 – Collegeville, Pennsylvania, Provepharm Inc. is voluntarily recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk...
Read More

Tags:

Previous Article

Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal S...

Next Article

Drug Safety Communication: Copaxone, Glatopa (glatiramer acetate) - FDA Adds Box...

Related Posts

FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy

FDA Requires Guillain-Barré Syndrome (GBS) Warning in t...

Feb 9, 2025  0

Drug Safety Communication: Copaxone, Glatopa (glatiramer acetate) - FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis

Drug Safety Communication: Copaxone, Glatopa (glatirame...

Feb 9, 2025  0

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fouzee Sugarlin Herbal Formula Due To Presence Of Undeclared Metformin And Glyburide

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fo...

Feb 9, 2025  0